Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the... see more

CSE:LIB - Post Discussion

Nova Mentis Life Science Corp. > The MJ Sector Is Starting To Look Promising Again :)
View:
Post by BiggerFish23 on Feb 21, 2018 12:32am

The MJ Sector Is Starting To Look Promising Again :)

Hopefully we get some good news soon :) https://www.cantechletter.com/2018/02/get-ready-for-an-upswing-in-the-cannabis-sector-canaccord-genuity-says/
Comment by frewil11 on Feb 21, 2018 10:33am
I guess we can hope to buy a company with an existing license but other than that we can only sit here and cross our fingers that HC starts to grant other companies licenses instead of just the big ones with all the money and HC officials in their back pocket.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities